Functional consequences of CD36 downregulation by TLR signals

Cytokine

Volumn 60, Issue 1, 2012, Pages 257-265

  Zamora, Carlos ^a   Cantó, Elisabet ^a   Nieto, Juan C ^a   Angels Ortiz, M ^a   Juarez, Candido ^b   Vidal, Sílvia ^a  

^a Institut Recerca Hospital S Pau   (Spain)

^b Hospital S Pau   (Spain)

Author keywords

Monocytes; Phagocytosis; Scavenger receptor

Indexed keywords

CD36 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

APOPTOSIS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANTIBODIES, NEUTRALIZING; ANTIGENS, CD36; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOPLASM; DIGLYCERIDES; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICROSCOPY, CONFOCAL; MONOCYTES; NEUTROPHILS; OLIGOPEPTIDES; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865439834     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.020     Document Type: Article

References (57)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Parker L.C., Prince L.R., Sabroe I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 2007, 147:199-207.
3. Hopkins P.A., Sriskandan S. Mammalian Toll-like receptors: to immunity and beyond. Clin Exp Immunol 2005, 140:395-407.
4. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., et al. Genetic analysis of host resistance. Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24:353-389.
5. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979-87 [quiz 88].
6. Blander J.M., Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004, 304:1014-1018.
7. Doyle S.E., O'Connell R.M., Miranda G.A., Vaidya S.A., Chow E.K., Liu P.T., et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004, 199:81-90.
8. Krutzik S.R., Tan B., Li H., Ochoa M.T., Liu P.T., Sharfstein S.E., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 2005, 11:653-660.
9. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291:1544-1547.
10. Blander J.M. Signalling and phagocytosis in the orchestration of host defence. Cell Microbiol 2007, 9:290-299.
11. Medzhitov R., Janeway C. Innate immunity. N Engl J Med 2000, 343:338-344.
12. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511.
13. Hallman M., Ramet M., Ezekowitz R.A. Toll-like receptors as sensors of pathogens. Pediatr Res 2001, 50:315-321.
14. Weaver L.K., Pioli P.A., Wardwell K., Vogel S.N., Guyre P.M. Up-regulation of human monocyte CD163 upon activation of cell-surface toll-like receptors. J Leukoc Biol 2007, 81:663-671.
15. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001, 108:785-791.
16. Nicholson A.C., Frieda S., Pearce A., Silverstein R.L. Binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 1995, 15:269-275.
17. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
18. Rigotti A., Acton S.L., Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224.
19. Ren Y., Silverstein R.L., Allen J., Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995, 181:1857-1862.
20. Asch A.S., Barnwell J., Silverstein R.L., Nachman R.L. Isolation of the thrombospondin membrane receptor. J Clin Invest 1987, 79:1054-1061.
21. Tandon N.N., Kralisz U., Jamieson G.A. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989, 264:7576-7583.
22. Barnwell J.W., Ockenhouse C.F., Knowles D.M. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J Immunol 1985, 135:3494-3497.
23. Huh H.Y., Pearce S.F., Yesner L.M., Schindler J.L., Silverstein R.L. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996, 87:2020-2028.
24. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382.
25. Adams D.O., Hamilton T.A. The cell biology of macrophage activation. Annu Rev Immunol 1984, 2:283-318.
26. Han J., Hajjar D.P., Tauras J.M., Feng J., Gotto A.M., Nicholson A.C. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J Biol Chem 2000, 275:1241-1246.
27. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., et al. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
28. Stuart L.M., Deng J., Silver J.M., Takahashi K., Tseng A.A., Hennessy E.J., et al. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 2005, 170:477-485.
29. Fadok V.A., Warner M.L., Bratton D.L., Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 1998, 161:6250-6257.
30. Cairns A.P., Crockard A.D., Bell A.L. CD36-mediated apoptotic cell clearance in SLE. Lupus 2001, 10:656-657.
31. Peiser L., Gordon S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect 2001, 3:149-159.
32. Mikolajczyk T.P., Skrzeczynska-Moncznik J.E., Zarebski M.A., Marewicz E.A., Wisniewska A.M., Dzieba M., et al. Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells. Immunology 2009, 128:103-113.
33. Yassin L.M., Rojas M., Ramirez L.A., Garcia L.F., Vasquez G. Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients. Cell Immunol 2010, 266:52-60.
34. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-80.
35. Triantafilou M., Gamper F.G., Haston R.M., Mouratis M.A., Morath S., Hartung T., et al. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 2006, 281:31002-31011.
36. Niebuhr M., Langnickel J., Sigel S., Werfel T. Dysregulation of CD36 upon TLR-2 stimulation in monocytes from patients with atopic dermatitis and the TLR2 R753Q polymorphism. Exp Dermatol 2010, 19:e296-298.
37. Triantafilou M., Gamper F.G., Lepper P.M., Mouratis M.A., Schumann C., Harokopakis E., et al. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 2007, 9:2030-2039.
38. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010, 11:155-161.
39. Boyer J.F., Balard P., Authier H., Faucon B., Bernad J., Mazieres B., et al. Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes. Arthritis Res Ther 2007, 9:R22.
40. Draude G., Lorenz R.L. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol 2000, 278:H1042-H1048.
41. Nozaki S., Kashiwagi H., Yamashita S., Nakagawa T., Kostner B., Tomiyama Y., et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 1995, 96:1859-1865.
42. Zurawski G., de Vries J.E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994, 15:19-26.
43. Han X., Kitamoto S., Lian Q., Boisvert W.A. Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages. J Biol Chem 2009, 284:32950-32958.
44. Lin J, Li M, Wang Z, He S, Ma X, Li D. The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation. J Lipid Res 51:1208-17.
45. Berry A., Balard P., Coste A., Olagnier D., Lagane C., Authier H., et al. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. Eur J Immunol 2007, 37:1642-1652.
46. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
47. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93:241-252.
48. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002, 168:3536-3542.
49. Wong K.L., Tai J.J., Wong W.C., Han H., Sem X., Yeap W.H., et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31.
50. Erdman L.K., Cosio G., Helmers A.J., Gowda D.C., Grinstein S., Kain K.C. CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J Immunol 2009, 183:6452-6459.
51. Jeannin P., Bottazzi B., Sironi M., Doni A., Rusnati M., Presta M., et al. Complexity and complementarity of outer membrane protein: a recognition by cellular and humoral innate immunity receptors. Immunity 2005, 22:551-560.
52. Baranova I.N., Kurlander R., Bocharov A.V., Vishnyakova T.G., Chen Z., Remaley A.T., et al. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 2008, 181:7147-7156.
53. Griffin E., Re A., Hamel N., Fu C., Bush H., McCaffrey T., et al. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 2001, 7:840-846.
54. Handberg A., Levin K., Hojlund K., Beck-Nielsen H. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. Circulation 2006, 114:1169-1176.
55. Lamharzi N., Renard C.B., Kramer F., Pennathur S., Heinecke J.W., Chait A., et al. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 2004, 53:3217-3225.
56. Sampson M.J., Davies I.R., Braschi S., Ivory K., Hughes D.A. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with type 2 diabetes. Atherosclerosis 2003, 167:129-134.
57. Zhao Z., de Beer M.C., Cai L., Asmis R., de Beer F.C., de Villiers W.J., et al. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler Thromb Vasc Biol 2005, 25:168-173.